Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis

Chick, RC; Faries, MB; Hale, DF; Bohan, PMK; Hickerson, AT; Vreeland, TJ; Myers, JW; Cindass, JL; Brown, TA; Hyngstrom, J; Berger, AC; Jakub, JW; Sussman, JJ; Shaheen, M; Clifton, GT; Park, H; Sloan, AJ; Wagner, T; Peoples, GE

Chick, RC (corresponding author), Ft Sam Houston, Brooke Army Med Ctr, Houston, TX 02115 USA.

CANCER MEDICINE, 2021; 10 (13): 4302

Abstract

Background Checkpoint inhibitors (CPI) in combination with cell-based vaccines may produce synergistic antitumor immunity. The primary analysis of the......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索